Formoterol Fumarate Solution
Product Images NDC 70748-261

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Formoterol Fumarate (NDC 70748-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (7c2eac38 F571 486e 91bb 60f913af5bbc 01)

Chemical structure diagram showing the molecular formulas of formoterol fumarate dihydrate, depicting two formoterol molecules and a fumaric acid molecule with two water molecules (dihydrate).*

FDA Label Image

Image (7c2eac38 F571 486e 91bb 60f913af5bbc 02)

A line graph comparing mean FEV1 (in liters) over 12 hours between formoterol fumarate inhalation solution 20 mcg and placebo groups. The x-axis represents hours from 0 to 12, and the y-axis represents mean FEV1 values from approximately 1.20 to 1.80 liters. The formoterol group shows a higher mean FEV1 across the time points compared to placebo.*

FDA Label Image

Image (7c2eac38 F571 486e 91bb 60f913af5bbc 03)

A line graph depicting mean FEV1 (in liters) over time (hours) for two groups: formoterol fumarate inhalation solution 20 mcg (N=123) and placebo (N=114). The formoterol group shows higher FEV1 values across the 12-hour period compared to placebo.*

FDA Label Image

1 (7c2eac38 F571 486e 91bb 60f913af5bbc 04)

FDA Label Image

Image (7c2eac38 F571 486e 91bb 60f913af5bbc 05)

An instructional illustration showing a hand holding an inhaler and another hand holding a small vial or cartridge, depicting the process of inserting or attaching the vial into the inhaler device. This image likely relates to the assembly or preparation of a respiratory inhalation solution device for formoterol fumarate inhalation.*

FDA Label Image

Image (7c2eac38 F571 486e 91bb 60f913af5bbc 06)

An instructional illustration showing a hand holding a respiratory inhalation solution device while another hand aligns a component to be inserted or attached. This diagram likely demonstrates part of the assembly or usage process of the formoterol fumarate respiratory inhalation solution device.*

FDA Label Image

Image (7c2eac38 F571 486e 91bb 60f913af5bbc 07)

Instructional black and white line drawings showing two steps of using a respiratory inhalation device for formoterol fumarate solution. The left image depicts a person inhaling directly from the device's mouthpiece, while the right image shows the device connected to a facemask covering the nose and mouth for inhalation.*

FDA Label Image

2 (7c2eac38 F571 486e 91bb 60f913af5bbc 08)

FDA Label Image

Pouch Label (7c2eac38 F571 486e 91bb 60f913af5bbc 09)

Formoterol Fumarate Inhalation Solution 20 mcg/2 mL vial packaging label. The label includes dosage information indicating a sterile unit-dose vial for oral inhalation use, with active ingredient formoterol fumarate and inactive constituents. Storage conditions specify refrigeration between 2°C to 8°C with instructions for room temperature storage before use. Manufactured by Lupin Pharmaceuticals, Inc., Naples, FL.*

FDA Label Image

Formoterol Fumarate Inhalation Solution20 Mcg/2 mL Vialndc 70748-261-30 Carton Contains: 30 Individual Wrapped 2 mL Unit Dose Vials (7c2eac38 F571 486e 91bb 60f913af5bbc 10)

Packaging label for formoterol fumarate inhalation solution 20 mcg/2 mL vial by Lupin Pharmaceuticals, Inc. The carton contains 30 individually wrapped sterile unit dose vials. The label shows the product name, strength, dosage form, active ingredient, and storage instructions. The NDC code 70748-261-30 is also visible along with barcodes and patient information details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.